Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesis

Details for Australian Patent Application No. 2006320440 (hide)

Owner Bayer HealthCare LLC

Inventors Parcella, Kyle; Zhang, Zhonghua; Hong, Zhenqiu; Newcom, Jason; Kluender, Harold; Chandler, Brent; Achebe, Furahi; Dixon, Julie; Magnuson, Steven; Wang, Lei; Liu, Zheng; Michels, Martin; Khire, Uday; O'Connor, Stephen J.; Phillips, Barton

Agent Davies Collison Cave

Pub. Number AU-B-2006320440

PCT Pub. Number WO2007/064931

Priority 60/741,691 02.12.05 US

Filing date 1 December 2006

Wipo publication date 7 June 2007

Acceptance publication date 5 April 2012

International Classifications

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 31/5377 (2006.01)

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

C07D 207/50 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 253/10 (2006.01) Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 267/10 (2006.01) Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

24 July 2008 PCT application entered the National Phase

  PCT publication WO2007/064931 Priority application(s): WO2007/064931

5 April 2012 Application Accepted

  Published as AU-B-2006320440

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006320444-Transvisceral neurostimulation mapping device and method

2006320435-Compositions containing ansamycin